As shown in Fig. 4, several targets belong to the estrogen receptor, such as ESR1 (estrogen receptor-α, degree = 5), ESR2 (estrogen receptor-β, degree = 5), and PGR (progesterone receptor, degree = 6), are major therapeutic targets of breast cancer. This evidence concerns the gene ESR1 and breast carcinoma.